Palacios S - Search Results

1

Endometrial safety assessment of a specific and standardized soy extract according to international guidelines.

Palacios S, Pornel B, Bergeron C, Chantre P, Nogales F, Aubert L, Vazquez F, Eden J, Mares P. Palacios S, et al. Menopause. 2007 Nov-Dec;14(6):1006-11. doi: 10.1097/gme.0b013e3180590c42. Menopause. 2007. PMID: 17603393 Clinical Trial.

2

Changes of the basement membrane and type IV collagen in human skin during aging.

Vázquez F, Palacios S, Alemañ N, Guerrero F. Vázquez F, et al. Among authors: palacios s. Maturitas. 1996 Nov;25(3):209-15. doi: 10.1016/s0378-5122(96)01066-3. Maturitas. 1996. PMID: 8981338

3

Pulsed estrogen therapy: relieving climacteric symptoms, preventing postmenopausal bone loss.

Palacios S. Palacios S. Climacteric. 2002 Jun;5 Suppl 2:32-9. Climacteric. 2002. PMID: 12482109 Review.

4

Raloxifene is not associated with biologically relevant changes in hot flushes in postmenopausal women for whom therapy is appropriate.

Palacios S, Farias ML, Luebbert H, Gomez G, Yabur JA, Quail DC, Turbi C, Kayath MJ, Almeida MJ, Mönnig E, Nickelsen T. Palacios S, et al. Am J Obstet Gynecol. 2004 Jul;191(1):121-31. doi: 10.1016/j.ajog.2003.10.701. Am J Obstet Gynecol. 2004. PMID: 15295352 Clinical Trial.

5

Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy.

Palacios S, Castelo-Branco C, Cancelo MJ, Vázquez F. Palacios S, et al. Maturitas. 2005 Feb 14;50(2):98-104. doi: 10.1016/j.maturitas.2004.04.007. Maturitas. 2005. PMID: 15653006 Clinical Trial.

6

Changes in bone turnover markers after calcium-enriched milk supplementation in healthy postmenopausal women: a randomized, double-blind, prospective clinical trial.

Palacios S, Castelo-Branco C, Cifuentes I, von Helde S, Baró L, Tapia-Ruano C, Menéndez C, Rueda C. Palacios S, et al. Menopause. 2005 Jan-Feb;12(1):63-8. doi: 10.1097/00042192-200512010-00012. Menopause. 2005. PMID: 15668602 Clinical Trial.

7

Available medical choices for the management of menopause.

Castelo-Branco C, Palacios S, Calaf J, Vázquez F, Lanchares JL. Castelo-Branco C, et al. Among authors: palacios s. Maturitas. 2005 Nov 15;52 Suppl 1:S61-70. doi: 10.1016/j.maturitas.2005.09.008. Epub 2005 Oct 4. Maturitas. 2005. PMID: 16213114 Review.

8

Neuroprotective effects of soy phytoestrogens in the rat brain.

Azcoitia I, Moreno A, Carrero P, Palacios S, Garcia-Segura LM. Azcoitia I, et al. Among authors: palacios s. Gynecol Endocrinol. 2006 Feb;22(2):63-9. doi: 10.1080/09513590500519161. Gynecol Endocrinol. 2006. PMID: 16603429

9

The future of the new selective estrogen receptor modulators.

Palacios S. Palacios S. Menopause Int. 2007 Mar;13(1):27-34. doi: 10.1258/175404507780456791. Menopause Int. 2007. PMID: 17448265 Review.

10

Effects on serum lipid and leptin levels of three different doses of norethisterone continuously combined with a fixed dose of 17beta-estradiol for nasal administration in postmenopausal women: a controlled, double-blind study.

Castelo-Branco C, Palacios S, Vázquez F, Villero J, Ferrer J, Ascaso C, Balasch J. Castelo-Branco C, et al. Among authors: palacios s. Fertil Steril. 2007 Aug;88(2):383-9. doi: 10.1016/j.fertnstert.2006.11.142. Epub 2007 Jun 11. Fertil Steril. 2007. PMID: 17561009 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

418 results

Search Page